Added to YB: 2015-09-23
Pitch date: 2015-09-23
TBPH:US [bullish]
Theravance Biopharma, Inc.
-39.52%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States.
Market Cap
N/A
Pitch Price
$28.11
Price Target
N/A
Dividend
N/A
EV/EBITDA
76.59
P/E
N/A
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Theravance Biopharma Inc TBPH:US
A summary for this pitch has not been created yet.
Read full article (0 min)